9 results
424B3
BBLNF
Babylon Holdings Ltd
17 Jun 22
Prospectus supplement
5:01pm
, packaging, safety, efficacy, premarket review, marketing, sales, distribution, import and export. A “device” is broadly defined under the FDCA to mean … devices their design, development, manufacturing, testing, labeling, packaging, safety, efficacy, premarket review or certification, marketing, sales
F-4
EX-10.14
BBLNF
Babylon Holdings Ltd
20 May 22
Registration of securities (foreign)
5:13pm
and packaging) of such copies of the Offering Documents (and all amendments or supplements thereto) as may, in each case, be reasonably requested for use
F-4
BBLNF
Babylon Holdings Ltd
20 May 22
Registration of securities (foreign)
5:13pm
including with respect to their design, development, manufacturing, testing, labeling, packaging, safety, efficacy, premarket review, marketing, sales … , manufacturing, testing, labeling, packaging, safety, efficacy, premarket review or certification, marketing, sales, distribution, import and export
424B3
BBLNF
Babylon Holdings Ltd
9 May 22
Prospectus supplement
4:15pm
, testing, labeling, packaging, safety, efficacy, premarket review, marketing, sales, distribution, import and export. A “device” is broadly defined … , with respect to medical devices their design, development, manufacturing, testing, labeling, packaging, safety, efficacy, premarket review
424B3
BBLNF
Babylon Holdings Ltd
3 May 22
Prospectus supplement
4:16pm
to extensive and rigorous regulation including with respect to their design, development, manufacturing, testing, labeling, packaging, safety, efficacy … , development, manufacturing, testing, labeling, packaging, safety, efficacy, premarket review or certification, marketing, sales, distribution, import
F-1
8r0n3j9fbq6q5h
29 Apr 22
Registration statement (foreign)
5:09pm
POS AM
8s0caa
28 Apr 22
Prospectus update (post-effective amendment)
5:28pm
424B3
a3xr49vzkhiqkwqbato
30 Mar 22
Prospectus supplement
5:19pm
20-F
k5m8h
30 Mar 22
Annual report (foreign)
4:12pm
- Prev
- 1
- Next